Search Results 31-40 of 19930 for Hepatitis b
This project in the Developmental Research Program of the Mayo Clinic Hepatobiliary SPORE is studying liver cancer associated with hepatitis B virus ...
This study will examine the balance between immune regulatory and effector responses in hepatitis B-infected participants enrolled in the HBRN study ( ...
Living with hepatitis B? Connect with others like you for support and answers to your questions in the Transplants support group on Mayo Clinic Connect, a ...
Low hepatitis B surface antigen antibody titers in fully vaccinated patients may not indicate a lack of immunity.
An esitimated three million Americans are infected. While other forms of the virus, like hepatitis A and hepatitis B, can generally be destroyed by your immune ...
Pregnant women who have hepatitis B infection or are carriers of hepatitis B virus can give the disease to their babies when they are born. These babies often ...
Study suggests that screening fully vaccinated inflammatory bowel disease (IBD) patients for hepatitis B immunity is not needed.
The immune response to gluten in these patients may interfere with developing immunity from vaccination for hepatitis B, according to some research, but not all ...
Telbivudine is not a cure for hepatitis B infection, but it may lower the amount of virus in your body and may decrease the ability of the virus to multiply.
The prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) in the United States (US) is relatively low. However, immigrant populations in the US ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!